Cargando…

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast

Ductal carcinoma in situ is a biologically diverse entity. Whereas some lesions are cured by local surgical excision, others recur as in situ disease or progress to invasive carcinoma with subsequent potential for metastatic spread. Reliable prognostic biomarkers are therefore desirable for appropri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Jia-Min B., Gorringe, Kylie L., Wong, Stephen Q., Dobrovic, Alexander, Campbell, Ian G., Fox, Stephen B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469314/ https://www.ncbi.nlm.nih.gov/pubmed/26078038 http://dx.doi.org/10.1186/s13058-015-0586-z

Ejemplares similares

DNA methylation in ductal carcinoma in situ of the breast
por: Pang, Jia-Min B, et al.
Publicado: (2013)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018)

BRCA2 carriers with male breast cancer show elevated tumour methylation
por: Deb, Siddhartha, et al.
Publicado: (2017)

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
por: Toss, Michael S., et al.
Publicado: (2020)

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
por: Miligy, Islam M., et al.
Publicado: (2019)

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
por: Toss, Michael S., et al.
Publicado: (2018)

LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness
por: Pang, Jia-Min B., et al.
Publicado: (2017)

Methylation profiling of ductal carcinoma in situand its relationship to histopathological features
por: Pang, Jia-Min B, et al.
Publicado: (2014)

No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer
por: Huang, Katie T, et al.
Publicado: (2009)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Youssef, Arkan, et al.
Publicado: (2021)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Single cell heterogeneity in ductal carcinoma in situ of breast
por: Gerdes, Michael J, et al.
Publicado: (2017)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy
por: Kinsey-Trotman, Stephen, et al.
Publicado: (2016)

Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings
por: Nadrljanski, Mirjan M., et al.
Publicado: (2013)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
por: Sagara, Yasuaki, et al.
Publicado: (2017)

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue
por: Kader, Tanjina, et al.
Publicado: (2016)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort
por: Gill, Jasmeet K, et al.
Publicado: (2006)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes
por: Hondow, Heather L, et al.
Publicado: (2011)

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
por: Wülfing, P, et al.
Publicado: (2005)

DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

PIK3CA mutations are frequently observed in BRCAX but not BRCA2 -associated male breast cancer
por: Deb, Siddhartha, et al.
Publicado: (2013)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Ductal Carcinoma In Situ of the Breast: A Surgical Perspective
por: Badruddoja, Mohammed
Publicado: (2012)

Case Report: Ductal Carcinoma In Situ in the Male Breast
por: Chern, Joshua, et al.
Publicado: (2012)

Ductal carcinoma in situ arising in tubular adenoma of the breast
por: Saimura, Michiyo, et al.
Publicado: (2012)

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
por: Luqmani, Y. A., et al.
Publicado: (1993)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology
por: Kricker, A, et al.
Publicado: (2004)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
por: Pinder, Sarah E, et al.
Publicado: (2003)

A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
por: Van Bockstal, Mieke R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gi6lqs947so3fonif21n8vofjm